Lee E T, Lee V S, Lu M, Lee J S, Russell D, Yeh J
Center for Epidemiologic Research, University of Oklahoma Health Sciences Center, Oklahoma City 73190.
Diabetes. 1994 Apr;43(4):572-9. doi: 10.2337/diab.43.4.572.
The incidence of and risk factors for renal failure were determined in 912 Oklahoma Indians with non-insulin-dependent diabetes mellitus in a follow-up study conducted between 1987 and 1990. The incidence rate was 15.7/1,000 person-years after an average follow-up time of 10.2 years. Among those who had no qualitatively positive proteinuria at baseline, the incidence of renal failure was 10.3/1,000 person-years compared with 19.3- and 56.2/1,000 person-years, respectively, in those with slight and heavy proteinuria at baseline. Fasting plasma glucose (FPG) > or = 11.1 mM (200 mg/dl) increased the risk of renal failure to 2.9-fold (95% confidence interval [CI] = 1.9-4.6) higher than a level < 7.8 mM (140 mg/dl), and twofold (95% CI = 1.4-3.1) higher than a level between 7.8 (140 mg/dl) and 11.1 mM (200 mg/dl). The hypertensive patient had twice the incidence of renal failure than the normotensive subject (rate ratio = 2.1, 95% CI = 1.4-3.0). Patients with a lower blood pressure under antihypertensive medication had a lower incidence of renal failure than those whose hypertension remained uncontrolled with or without use of medication. Significant independent risk factors for renal failure, identified from Cox's proportional hazards model, were duration of diabetes, FPG, age, hypertension, and insulin use (P < 0.05). In patients without proteinuria at baseline, FPG and hypertension were significant predictors of renal failure as identified by multivariate analyses, whereas in patients who had proteinuria at baseline, insulin use was significant. Thus, hyperglycemic and hypertension control are suggested strongly for diabetic Oklahoma Indians as potential strategies to prevent the development of renal failure.
在1987年至1990年进行的一项随访研究中,对912名患有非胰岛素依赖型糖尿病的俄克拉荷马印第安人肾衰竭的发病率和危险因素进行了测定。平均随访10.2年后,发病率为15.7/1000人年。在基线时无定性阳性蛋白尿的患者中,肾衰竭发病率为10.3/1000人年,而基线时轻度和重度蛋白尿患者的发病率分别为19.3/1000人年和56.2/1000人年。空腹血糖(FPG)≥11.1 mM(200 mg/dl)使肾衰竭风险比低于7.8 mM(140 mg/dl)时高出2.9倍(95%置信区间[CI]=1.9 - 4.6),比7.8(140 mg/dl)至11.1 mM(200 mg/dl)之间的水平高出两倍(95% CI = 1.4 - 3.1)。高血压患者肾衰竭发病率是血压正常者的两倍(率比=2.1,95% CI = 1.4 - 3.0)。接受抗高血压药物治疗且血压较低的患者肾衰竭发病率低于高血压未得到控制(无论是否用药)的患者。从Cox比例风险模型中确定的肾衰竭显著独立危险因素为糖尿病病程、FPG、年龄、高血压和胰岛素使用(P<0.05)。在基线时无蛋白尿的患者中,多变量分析确定FPG和高血压是肾衰竭的显著预测因素,而在基线时有蛋白尿的患者中,胰岛素使用具有显著意义。因此,强烈建议对患有糖尿病的俄克拉荷马印第安人进行血糖和血压控制,作为预防肾衰竭发生的潜在策略。